BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 24447423)

  • 1. Human antibody responses to avian influenza A(H7N9) virus, 2013.
    Guo L; Zhang X; Ren L; Yu X; Chen L; Zhou H; Gao X; Teng Z; Li J; Hu J; Wu C; Xiao X; Zhu Y; Wang Q; Pang X; Jin Q; Wu F; Wang J
    Emerg Infect Dis; 2014 Feb; 20(2):192-200. PubMed ID: 24447423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inactivated H7 Influenza Virus Vaccines Protect Mice despite Inducing Only Low Levels of Neutralizing Antibodies.
    Kamal RP; Blanchfield K; Belser JA; Music N; Tzeng WP; Holiday C; Burroughs A; Sun X; Maines TR; Levine MZ; York IA
    J Virol; 2017 Oct; 91(20):. PubMed ID: 28768855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suboptimal Humoral Immune Response against Influenza A(H7N9) Virus Is Related to Its Internal Genes.
    Lee AC; Zhu H; Zhang AJ; Li C; Wang P; Li C; Chen H; Hung IF; To KK; Yuen KY
    Clin Vaccine Immunol; 2015 Dec; 22(12):1235-43. PubMed ID: 26446420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the Immune Responses to and Cross-Protective Efficacy of Eurasian H7 Avian Influenza Viruses.
    Kwon HI; Kim YI; Park SJ; Song MS; Kim EH; Kim SM; Si YJ; Lee IW; Song BM; Lee YJ; Yun SJ; Kim WJ; Choi YK
    J Virol; 2017 Jun; 91(11):. PubMed ID: 28331080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Profiles of acute cytokine and antibody responses in patients infected with avian influenza A H7N9.
    Huang R; Zhang L; Gu Q; Zhou YH; Hao Y; Zhang K; Liu Y; Dong D; Wang S; Huang Z; Lu S; Wu C
    PLoS One; 2014; 9(7):e101788. PubMed ID: 25003343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum strain-specific or cross-reactive neuraminidase inhibiting antibodies against pandemic А/California/07/2009(H1N1) influenza in healthy volunteers.
    Desheva YA; Smolonogina TA; Donina SA; Rudenko LG
    BMC Res Notes; 2015 Apr; 8():136. PubMed ID: 25889924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of Humoral Responses Induced by an H7N9 Influenza Virus-Like Particle Vaccine in BALB/C Mice.
    Zhang L; Lu J; Chen Y; Shi F; Yu H; Huang C; Cui L; Shi Z; Jiao Y; Hu Y
    Viruses; 2015 Aug; 7(8):4369-84. PubMed ID: 26248076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IgM, IgG, and IgA antibody responses to influenza A(H1N1)pdm09 hemagglutinin in infected persons during the first wave of the 2009 pandemic in the United States.
    Li ZN; Lin SC; Carney PJ; Li J; Liu F; Lu X; Liu M; Stevens J; Levine M; Katz JM; Hancock K
    Clin Vaccine Immunol; 2014 Aug; 21(8):1054-60. PubMed ID: 24872516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A recombinant H7N9 influenza vaccine with the H7 hemagglutinin transmembrane domain replaced by the H3 domain induces increased cross-reactive antibodies and improved interclade protection in mice.
    Wang Y; Wu J; Xue C; Wu Z; Lin Y; Wei Y; Wei X; Qin J; Zhang Y; Wen Z; Chen L; Liu GD; Cao Y
    Antiviral Res; 2017 Jul; 143():97-105. PubMed ID: 28408133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. L226Q Mutation on Influenza H7N9 Virus Hemagglutinin Increases Receptor-Binding Avidity and Leads to Biased Antigenicity Evaluation.
    Wang Y; Lv Y; Niu X; Dong J; Feng P; Li Q; Xu W; Li J; Li C; Li J; Luo J; Li Z; Liu Y; Tan YJ; Pan W; Chen L
    J Virol; 2020 Sep; 94(20):. PubMed ID: 32796071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and optimized pairing of mouse monoclonal antibodies for detecting hemagglutinin in novel H7 subtype influenza viruses.
    Wang H; Zhou J; Wang D; Huang B; Tan W
    Sci China Life Sci; 2020 Feb; 63(2):279-289. PubMed ID: 31147904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Population seroprevalence of antibody to influenza A(H7N9) virus, Guangzhou, China.
    Lin YP; Yang ZF; Liang Y; Li ZT; Bond HS; Chua H; Luo YS; Chen Y; Chen TT; Guan WD; Lai JCC; Siu YL; Pan SH; Peiris JSM; Cowling BJ; Mok CKP
    BMC Infect Dis; 2016 Nov; 16(1):632. PubMed ID: 27814756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of Broadly Cross-Reactive Stalk-Specific Antibody Responses to Influenza Group 1 and Group 2 Hemagglutinins by Natural H7N9 Virus Infection in Humans.
    Liu L; Nachbagauer R; Zhu L; Huang Y; Xie X; Jin S; Zhang A; Wan Y; Hirsh A; Tian D; Shi X; Dong Z; Yuan S; Hu Y; Krammer F; Zhang X; Xu J
    J Infect Dis; 2017 Feb; 215(4):518-528. PubMed ID: 28380622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A cross-reactive human monoclonal antibody targets the conserved H7 antigenic site A from fifth wave H7N9-infected humans.
    Li M; Chen L; Wang Q; Hao M; Zhang X; Liu L; Yu X; Yang C; Xu J; Chen J; Gong R
    Antiviral Res; 2019 Oct; 170():104556. PubMed ID: 31299269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preexisting Antibody-Dependent Cellular Cytotoxicity-Activating Antibody Responses Are Stable Longitudinally and Cross-reactive Responses Are Not Boosted by Recent Influenza Exposure.
    Valkenburg SA; Zhang Y; Chan KY; Leung K; Wu JT; Poon LL
    J Infect Dis; 2016 Oct; 214(8):1159-63. PubMed ID: 27493238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Varying Doses of a Monovalent H7N9 Influenza Vaccine With and Without AS03 and MF59 Adjuvants on Immune Response: A Randomized Clinical Trial.
    Jackson LA; Campbell JD; Frey SE; Edwards KM; Keitel WA; Kotloff KL; Berry AA; Graham I; Atmar RL; Creech CB; Thomsen IP; Patel SM; Gutierrez AF; Anderson EL; El Sahly HM; Hill H; Noah DL; Bellamy AR
    JAMA; 2015 Jul; 314(3):237-46. PubMed ID: 26197184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimal designs of an HA-based DNA vaccine against H7 subtype influenza viruses.
    Zhang L; Jia N; Li J; Han Y; Cao W; Wang S; Huang Z; Lu S
    Hum Vaccin Immunother; 2014; 10(7):1949-58. PubMed ID: 25424804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of H7N9-Cross-Reactive Antibody-Dependent Cellular Cytotoxicity Antibodies by Human Seasonal Influenza A Viruses that are Directed Toward the Nucleoprotein.
    Jegaskanda S; Co MDT; Cruz J; Subbarao K; Ennis FA; Terajima M
    J Infect Dis; 2017 Mar; 215(5):818-823. PubMed ID: 28011910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of rapid immunochromatographic test for hemagglutinin antigen of H7 subtype in patients infected with novel avian influenza A (H7N9) virus.
    Kang K; Chen L; Zhao X; Qin C; Zhan Z; Wang J; Li W; Dzakah EE; Huang W; Shu Y; Jiang T; Cao W; Xie M; Luo X; Tang S
    PLoS One; 2014; 9(3):e92306. PubMed ID: 24647358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cross-reactivity between avian influenza A (H7N9) virus and divergent H7 subtypic- and heterosubtypic influenza A viruses.
    Guo L; Wang D; Zhou H; Wu C; Gao X; Xiao Y; Ren L; Paranhos-Baccalà G; Shu Y; Jin Q; Wang J
    Sci Rep; 2016 Feb; 6():22045. PubMed ID: 26907865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.